NCT01354977

Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Albert Einstein College of Medicine · Academic / Other
• Sex: All
• Age: 45 Years – 65 Years
• Healthy volunteers: Accepted

Summary

Resveratrol is a natural polyphenol (a compound containing a phenol functional group) that can be found in many plants. The purpose of this research is to study the effects of resveratrol on the action of insulin (a hormone produced in the body by the pancreas that regulates the amount of sugar in the blood), fat accumulation, and inflammation in the body.

Detailed description

Participants will meet with the study team to discuss dietary recommendations. Each participant will be instructed to follow a standardized diet plan and to avoid vigorous exercise before beginning the study. Participants will be given a 28 day supply of resveratrol capsules (Two 500 mg capsules taken twice a day). A comprehensive study of whole-body insulin action called a pancreatic clamp will be done and small samples of fat and muscle will be taken before and after the administration of resveratrol.

Conditions

• Type 2 Diabetes Mellitus
• Insulin Resistance

Interventions

Type	Name	Description
DRUG	Resveratrol	1,000mg twice daily for 28 days

Timeline

• Start date: 2008-03-01
• Primary completion: 2017-09-15
• Completion: 2017-09-15
• First posted: 2011-05-17
• Last updated: 2022-03-08
• Results posted: 2022-03-08

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study